The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The Active Sites of the Eukaryotic 20 S Proteasome and Their Involvement in Subunit Precursor Processing
Open accessAbstract
The 26 S proteasome is the central protease involved in ubiquitin-mediated protein degradation and fulfills vital regulatory functions in eukaryotes. The proteolytic core of the complex is the 20 S proteasome, a cylindrical particle with two outer rings each made of 7 different alpha-type subunits and two inner rings made of 7 different beta-type subunits. In the archaebacterial 20 S proteasome ancestor proteolytically active sites reside in the 14 uniform beta-subunits. Their N-terminal threonine residues, released by precursor processing, perform the nucleophilic attack for peptide bond hydrolysis. By directed mutational analysis of 20 S proteasomal beta-type proteins of Saccharomyces cerevisiae, we identified three active site-carrying subunits responsible for different peptidolytic activities as follows: Pre3 for post-glutamyl hydrolyzing, Pup1 for trypsin-like, and Pre2 for chymotrypsin-like activity. Double mutants harboring only trypsin-like or chymotrypsin-like activity were viable. Mutation of two potentially active site threonine residues in the Pre4 subunit excluded its catalytic involvement in any of the three peptidase activities. The generation of different, incompletely processed forms of the Pre4 precursor in active site mutants suggested that maturation of non-active proteasomal beta-type subunits is exerted by active subunits and occurs in the fully assembled particle. This trans-acting proteolytic activity might also account for processing intermediates of the active site mutated Pre2 subunit, which was unable to undergo autocatalytic maturation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sikorski, R. S., & Hieter, P. (1989) · Genetics · doi:10.1093/genetics/122.1.19 · Cited by 8,664
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Multifunctional yeast high-copy-number shuttle vectors
Christianson, T. W., Sikorski, R. S., Dante, M., Shero, J. H., & Hieter, P. (1992) · Gene · doi:10.1016/0378-1119(92)90454-w · Cited by 1,658
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution
Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,525
The "megaprimer" method of site-directed mutagenesis.
Sarkar, G., & Sommer, S. S. (1990) · PubMed · Cited by 1,165
Ubiquitin, proteasomes, and the regulation of intracellular protein degradation
Hochstrasser, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80031-x · Cited by 874
ER Degradation of a Misfolded Luminal Protein by the Cytosolic Ubiquitin-Proteasome Pathway
Hiller, M. M., Finger, A., Schweiger, M., & Wolf, D. H. (1996) · Science · doi:10.1126/science.273.5282.1725 · Cited by 708
Self-citationProteasome from Thermoplasma acidophilum : a Threonine Protease
Seemüller, E., Lupas, A., Stock, D., Löwe, J., Huber, R., & Baumeister, W. (1995) · Science · doi:10.1126/science.7725107 · Cited by 634
Cited by
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B., et al. (2004) · Nature · doi:10.1038/nature02371 · Cited by 1,065
AAA+ Proteases: ATP-Fueled Machines of Protein Destruction
Sauer, R. T., & Baker, T. A. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060408-172623 · Cited by 762
The ubiquitin-proteasome system
Nandi, D., Tahiliani, P., Kumar, A., & Chandu, D. (2006) · Journal of Biosciences · doi:10.1007/bf02705243 · Cited by 758
A resource for large-scale RNA-interference-based screens in mammals
Paddison, P. J., Silva, J. M., Conklin, D. S., Schlabach, M., Li, M., Aruleba, S., Balija, V., O'Shaughnessy, A., Gnoj, L., Scobie, K., et al. (2004) · Nature · doi:10.1038/nature02370 · Cited by 695
The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes
Kisselev, A. F., Akopian, T. N., Woo, K. M., & Goldberg, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3363 · Cited by 573
Mechanisms of cross‐talk between the ubiquitin‐proteasome and autophagy‐lysosome systems
Korolchuk, V. I., Menzies, F. M., & Rubinsztein, D. C. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.047 · Cited by 568
Leone, P., Shin, E.-C., Perosa, F., Vacca, A., Dammacco, F., & Racanelli, V. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt184 · Cited by 553
Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48
Jarosch, E., Taxis, C., Volkwein, C., Bordallo, J., Finley, D., Wolf, D. H., & Sommer, T. (2002) · Nature Cell Biology · doi:10.1038/ncb746 · Cited by 532
Self-citationProteasome Inhibitors: An Expanding Army Attacking a Unique Target
Kisselev, A. F., van der Linden, W. A., & Overkleeft, H. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.003 · Cited by 527
Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo
Nam, S., Smith, D. M., & Dou, Q. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004209200 · Cited by 504
Groll, M., Berkers, C. R., Ploegh, H. L., & Ovaa, H. (2006) · Structure · doi:10.1016/j.str.2005.11.019 · Cited by 473
Bochtler, M., Ditzel, L., Groll, M., Hartmann, C., & Huber, R. (1999) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.28.1.295 · Cited by 435
Kisselev, A. F., Callard, A., & Goldberg, A. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509043200 · Cited by 416
20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
Borissenko, L., & Groll, M. (2007) · Chemical Reviews · doi:10.1021/cr0502504 · Cited by 407
Jung, T., Catalgol, B., & Grune, T. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.001 · Cited by 389
Toes, R. E. M., Nussbaum, A. K., Degermann, S., Schirle, M., Emmerich, N. P. N., Kraft, M., Laplace, C., Zwinderman, A., Dick, T. P., Müller, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.1 · Cited by 371
Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide Substrates
Kisselev, A. F., & Goldberg, A. L. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)98030-0 · Cited by 346
Unconventional serine proteases: Variations on the catalytic Ser/His/Asp triad configuration
Ekici, Ö. D., Paetzel, M., & Dalbey, R. E. (2008) · Protein Science · doi:10.1110/ps.035436.108 · Cited by 334
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
Baranello, R., Bharani, K., Padmaraju, V., Chopra, N., Lahiri, D., Greig, N., Pappolla, M., & Sambamurti, K. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218140953 · Cited by 331
“Pharmacological inhibition of the proteasome is sufficient to induce neurodegeneration and cell death [93-95], demonstrating its importance in cellular homeostasis.”
BackgroundRamos, P. C., Höckendorff, J., Johnson, E. S., Varshavsky, A., & Dohmen, R. J. (1998) · Cell · doi:10.1016/s0092-8674(00)80942-3 · Cited by 326
Meiners, S., Heyken, D., Weller, A., Ludwig, A., Stangl, K., Kloetzel, P.-M., & Krüger, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301032200 · Cited by 318
Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1
Nussbaum, A. K., Dick, T. P., Keilholz, W., Schirle, M., Stevanović, S., Dietz, K., Heinemeyer, W., Groll, M., Wolf, D. H., Huber, R., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12504 · Cited by 311
Self-citationCatalytic Activities of the 20 S Proteasome, a Multicatalytic Proteinase Complex
Orlowski, M., & Wilk, S. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2036 · Cited by 308
Groll, M., Heinemeyer, W., Jäger, S., Ullrich, T., Bochtler, M., Wolf, D. H., & Huber, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10976 · Cited by 300
Self-citationProteasome inhibitors in cancer therapy
Crawford, L. J., Walker, B., & Irvine, A. E. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0121-7 · Cited by 299
Rubin, D. M., Glickman, M. H., Larsen, C. N., Dhruvakumar, S., & Finley, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.4909 · Cited by 297
Antigen presentation by MHC class I and its regulation by interferon γ
Früh, K., & Yang, Y. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80014-4 · Cited by 297
Kisselev, A. F., Akopian, T. N., Castillo, V., & Goldberg, A. L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80341-x · Cited by 292
IFN-γ-induced immune adaptation of the proteasome system is an accelerated and transient response
Heink, S., Ludwig, D., Kloetzel, P.-M., & Krüger, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501711102 · Cited by 288
Tanoka, K., & Kasahara, M. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01195.x · Cited by 282
Prediction of proteasome cleavage motifs by neural networks
Keşmir, C., Nussbaum, A. K., Schild, H., Detours, V., & Brunak, S. (2002) · Protein Engineering, Design and Selection · doi:10.1093/protein/15.4.287 · Cited by 282
The proteasome: a proteolytic nanomachine of cell regulation and waste disposal
Wolf, D. H., & Hilt, W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.10.007 · Cited by 270
Self-citationThe ubiquitin‐proteasome system in Alzheimer's disease
Oddo, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00276.x · Cited by 264
Dick, T. P., Nussbaum, A. K., Deeg, M., Heinemeyer, W., Groll, M., Schirle, M., Keilholz, W., Stevanović, S., Wolf, D. H., Huber, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25637 · Cited by 260
Self-citationMolecular Targets for Green Tea in Prostate Cancer Prevention
Adhami, V. M., Ahmad, N., & Mukhtar, H. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.7.2417s · Cited by 253
Das, D. S., Ray, A., Song, Y., Richardson, P., Trikha, M., Chauhan, D., & Anderson, K. C. (2015) · British Journal of Haematology · doi:10.1111/bjh.13780 · Cited by 49
Sampaio-Marques, B., Pereira, H., Santos, A. R., Teixeira, A., & Ludovico, P. (2018) · Aging · doi:10.18632/aging.101675 · Cited by 14
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Park, J., Park, E., Jung, C.-K., Kang, S.-W., Kim, B. G., Jung, Y., Kim, T. H., Lim, J.-Y., Lee, S.-E., Min, C.-K., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2285-2 · Cited by 9
Metadata
- Authors
- Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., & Wolf, D. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 272
- Issue
- 40
- Pages
- 25200-25209
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1969894269
- Cited by
- 519
- References
- 51
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.